US HB9321 | 2021-2022 | 117th Congress
Status
Sponsorship: Partisan Bill (Democrat 3)
Status: Introduced on November 16 2022 - 25% progression, died in committee
Action: 2022-11-17 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on November 16 2022 - 25% progression, died in committee
Action: 2022-11-17 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Public Health Service Act to provide for the development and publication of independent value assessments for drugs, and for other purposes.
Title
Independent Drug Value Assessment Act
Sponsors
| Rep. Jackie Speier [D-CA] | Rep. Jerrold Nadler [D-NY] | Rep. Katie Porter [D-CA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2022-11-17 | House | Referred to the Subcommittee on Health. |
| 2022-11-16 | House | Referred to the House Committee on Energy and Commerce. |
| 2022-11-16 | House | Introduced in House |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/117th-congress/house-bill/9321/all-info |
| Text | https://www.congress.gov/117/bills/hr9321/BILLS-117hr9321ih.pdf |
